Heise, Mark

Mark T. Heise is a researcher in the Department of Epidemiology at the University of North Carolina-Chapel Hill. He has contributed to studies on Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV). His work includes designing, coordinating, and executing experiments, analyzing data, and writing manuscripts. He has also collaborated with other researchers to develop critical monoclonal antibody reagents. Ralph S. Baric is a professor in the Departments of Cancer Immunology and AIDS at Dana-Farber Cancer Institute and Harvard Medical School, as well as in the Departments of Genetics and Microbiology and Immunology at the University of North Carolina-Chapel Hill. He has conceived/designed experiments, written manuscripts, supervised research on MERS-CoV and SARS-CoV, and provided critical monoclonal antibody reagents. Adam S. Cockrell is a researcher in the Department of Cancer Immunology and AIDS at Dana-Farber Cancer Institute and Harvard Medical School, as well as in the Departments of Microbiology and Immunology at the University of North Carolina-Chapel Hill. He has contributed to studies on MERS-CoV by developing infectious clone viruses, completing mouse experiments, and designing immunological experiments. Trevor Scobey is a researcher in the Department of Cancer Immunology and AIDS at Dana-Farber Cancer Institute and Harvard Medical School. He has completed mouse experiments related to MERS-CoV. Kara Jensen is a researcher in the Departments of Microbiology and Immunology at the University of North Carolina-Chapel Hill. She has helped establish and maintain the mouse colony, as well as perform molecular analyses related to MERS-CoV. Anne Beall is a researcher in the Departments of Microbiology and Immunology at the University of North Carolina-Chapel Hill. She has helped complete mouse experiments related to MERS-CoV. Xian-Chun Tang and Wayne A. Marasco are researchers in the Department of Medicine at Harvard Medical School, as well as in the Departments of Microbiology and Immunology at the University of North Carolina-Chapel Hill. They have provided critical monoclonal antibody reagents for studies on MERS-CoV.